Excellent response to chemotherapy post immunotherapy.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 29207685)

Published in Oncotarget on August 08, 2017

Authors

Ashish D Dwary¹, Samip Master¹, Abhishek Patel¹, Constance Cole¹, Richard Mansour¹, Glenn Mills¹, Nebu Koshy¹, Prakash Peddi¹, Gary Burton¹, Dalia Hammoud¹, Kavitha Beedupalli¹

Author Affiliations

1: Department of Medicine, Division of Hematology-Oncology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

Articles by these authors ⇆

Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment. Onco Targets Ther (2016) 0.75

Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight. Onco Targets Ther (2016) 0.75